- Category
- China Equity
- Total Assets
- 24.35B
- Expenses
- 2.41%
- Inception Date
- Jan 19, 2015
- Address
- 33A, avenue J.-F. Kennedy, L-1855 Luxembourg Luxembourg, L-1855, Luxembourg
- Phone
- +352-441 0101
- Fax
- -
|
Name
|
Title
|
Since
|
Until
|
Biography
|
|---|---|---|---|---|
| Morris | Research Analyst | 2019 | - | Morris is a member of the Global Emerging Markets and Asia Pacific Equities team and is responsible for investment analysis of China/Hong Kong equities. Morris joined UBS Global Asset Management in May 2015. Prior to this, he was a consulting director at BDA China, providing investment advisory services to top tier hedge funds and private equity funds for their investments in China. Morris worked at BDA for 9 years and specialized in the Consumer and TMT sectors. |
| Denise | 2018 | - | ||
| Bin | Portfolio Manager | 2015 | - | Bin Shi is a member of the Global Emerging Market and Asia Pacific Equities team, located in Hong Kong. He is Country Analyst and Portfolio Manager for China with a focus on Chinese stocks listed on both the overseas and domestic Chinese stock exchanges. Prior to joining UBS Asset Management, Bin spent three years as Head of Int’l Business, portfolio manager and analyst with Boshi Fund Management Co., one of the largest domestic mutual fund companies in China. Prior to that, he worked in the US for eight years as portfolio manager and analyst for several US mutual fund firms. Bin joined UBS in January 2006 and has managed the Greater China Fund since April 2006. |
| Yu | 2018 | 2019 | ||
| Derrick | 2018 | 2018 | Derrick Sun is a member of the Global Emerging Markets and Asian Pacific Equities team and is responsible for investment analysis of China/Hong Kong Equities. Derrick joined UBS Asset Management in July 2013. Prior to this, he was head of research for healthcare and small & mid-cap with Bank of China International (BOCI) and BNP Paribas. Previous industry experience includes 5 years managing a bio-pharmaceutical company’s Shanghai subsidiary and 5 years in Deloitte Consulting (US) where he provided business consulting services to Fortune 500 healthcare and consumer companies. | |
| Projit | 2010 | 2018 | Projit Chatterjee is a Senior Equity Specialist within the Global Emerging Markets and Asia Pacific Equities team at UBS Asset Management, based in Singapore. He is also a member of the Global Emerging Markets Strategy Committee and co-manager of the GEM High Dividend funds. Projit has primary responsibility for overall product positioning and development of Emerging Markets and Asian Equity strategies, as well as marketing and communication of these strategies to existing and prospective clients globally. Projit joined UBS in 1997 as a Corporate Finance Analyst with UBS Investment Bank in Mumbai, India. In 1999, he moved to UBS Asset Management in Zurich to work in Strategic Projects, International Fund Marketing. In Zurich, Projit held various roles in the areas of strategic business development, business management and investment solutions. He also led an acquisition project in the Indian market. Before joining UBS, Projit worked as a money market and foreign exchange dealer in the treasury of MashreqBank, a UAE bank in Mumbai. | |
| Hai | 2010 | 2015 | ||
| Management | 1996 | 2010 | Team Managed |
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
